Seven NGOs, including HEAL, sent this letter working on the protection of health to the REACH Committee regarding its discussion on the restriction of PFHxA under the REACH Regulation and on the restriction on lead in ammunition for hunting, outdoor sports shooting and in fishing.
Join us for a special webinar organised by the CHE EDC Strategies Partnership, where Dr. Eleni Papadopoulou from the Norwegian Institute of Public Health will present her study on how prenatal and postnatal exposure to per- and polyfluoroalkyl substances (PFAS) affects child cardiometabolic health and inflammatory biomarkers.
Wednesday 23rd February, 18:00 – 18:30 CET
Developing children are particularly vulnerable to the effects of exposure to PFAS, a group of endocrine disrupting chemicals. During the webinar, Dr. Papadopoulou will present the data published in Environmental International in December 2021, which are relevant when considering long-term health effects associated with PFAS exposure at early life stage for metabolic disorders and overall call for a more restrictive approach to the regulation of those chemicals.
This study is part of the EU-funded HELIX project, a collaboration across six ongoing longitudinal population-based birth cohort studies in Europe: the Born in Bradford (BiB) study in the UK, the Étude des Déterminants pré et postnatals du développement et de la santé de l’Enfant (EDEN) study in France, the INfancia y Medio Ambiente (INMA) cohort in Spain, the Kaunas cohort (KANC) in Lithuania, the Norwegian Mother, Father and Child Cohort Study (MoBa) and the RHEA Mother Child Cohort study in Crete, Greece.
This work is continuing in the ATHLETE project. The ATHLETE cohorts, including the HELIX participants, have assessed early (embryonic, fetal, and infant) organ development using cutting-edge measurements of advanced cardiac and great vessel imaging (anatomical and functional echocardiography and MRI), as well as trajectories of cardiometabolic health (e.g., blood pressure, macrovascular and microvascular phenotypes, weight gain, lipid profiles) into adolescence.
Dr. Eleni Papadopoulou is an epidemiologist and a researcher in the Global Health Cluster at the Norwegian Institute of Public Health. With a background in nutritional science and a PhD in environmental epidemiology, her work is focused on the potential effects of early life exposures to environmental contaminants, especially food contaminants, on fetal and childhood growth and metabolic health.
As a Marie Skłodowska-Curie Actions fellow she has studied dietary exposures to emerging toxicants, including PFAS, and her work has contributed to the recent risk assessment for PFAS in food by EFSA (adopted in July 2020) and the ongoing risk-benefit assessment of fish in the Norwegian diet by the Norwegian Scientific Committee for Food and Environment. As a researcher in the pioneering HELIX project she has studied the exposome, describing the totality of the environmental stressors we are exposed to. She is currently involved in global health research in several LMICs, including Palestine, Ethiopia, Uganda and Rwanda.
This webinar will be moderated by Génon Jensen, Executive Director of Health and Environment Alliance (HEAL). It will last for 30 minutes and will be recorded for our call and webinar archive.
The webinar builds on the CHE EDC Strategies Partnership’s PFAS, Science and Policy webinar series, which includes webinars featuring leading scientists presentations on topics such as the safety of fluoropolymers and connection to PFAS, the concept of essentiality as a means to phase out all but the most needed uses of PFAS and proposed actions on PFAS within the regulatory bodies of the EU as set out in EU Chemicals Strategy for Sustainability.